[IUK] Advancing Innovation in Accelerated Cancer Diagnosis
Accelerate diagnostic innovations that enable the earlier detection and diagnosis of cancer. Support the clinical validation and evaluation of innovative diagnostic technologies and devices. Generate robust evidence supporting: Clinical effectiveness and safety. Regulatory approval. Health economic benefits. Future NHS adoption. Projects addressing less common cancers are particularly encouraged. These are cancers outside breast, prostate, lung and bowel cancer, although rare forms of these four cancers can qualify.
Next deadline
Date to be confirmed
What it funds
Accelerate diagnostic innovations that enable the earlier detection and diagnosis of cancer. Support the clinical validation and evaluation of innovative diagnostic technologies and devices. Generate robust evidence supporting: Clinical effectiveness and safety. Regulatory approval. Health economic benefits. Future NHS adoption. Projects addressing less common cancers are particularly encouraged. These are cancers outside breast, prostate, lung and bowel cancer, although rare forms of these four cancers can qualify.
Who it suits
Consortium requirements This is a collaborative competition. The lead can be a UK-registered: Business of any size. Academic institution. NHS organisation. The consortium must include at least one UK-registered SME claiming grant funding. The project must include a practising clinician, clinical ac…
- Life sciences & health
- Industrial R&D
Programme specifications
Considering [IUK] Advancing Innovation in Accelerated Cancer Diagnosis?
Talk through your project with a specialist and find out whether this is the right competition before you invest time in an application.